Artículos por temáticas

Dependency criterion based brain pathological age estimation of Alzheimer's disease patients with MR scans

Li Y, Liu Y, Wang P, Wang J, Xu S, Qiu M; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Biomed Eng Online. 2017 Apr 24;16(1):50. doi: 10.1186/s12938-017-0342-y.

Small vessel disease is linked to disrupted structural network covariance in Alzheimer's disease

Nestor SM, Mišić B, Ramirez J, Zhao J, Graham SJ, Verhoeff NPLG, Stuss DT, Masellis M, Black SE.

Alzheimers Dement. 2017 Jul;13(7):749-760. doi: 10.1016/j.jalz.2016.12.007. Epub 2017 Jan 27.

An assessesment of telephone assistance systems for caregivers of patients with Alzheimer's disease

Garzón-Maldonado FJ, Gutiérrez-Bedmar M, Serrano-Castro V, Requena-Toro MV, Padilla-Romero L, García-Casares N.

Neurologia. 2017 Nov-Dec;32(9):595-601. doi: 10.1016/j.nrl.2016.03.009. Epub 2016 Jun 10.

Cholinergic symptoms and QTc prolongation following donepezil overdose

Pourmand A, Shay C, Redha W, Aalam A, Mazer-Amirshahi M.

Am J Emerg Med. 2017 Sep;35(9):1386.e1-1386.e3. doi: 10.1016/j.ajem.2017.06.044. Epub 2017 Jun 22.

Typical and atypical appearance of early-onset Alzheimer's disease: A clinical, neuroimaging and neuropathological study

Kawakatsu S, Kobayashi R, Hayashi H.

Neuropathology. 2017 Apr;37(2):150-173. doi: 10.1111/neup.12364. Epub 2017 Jan 17.

Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients

Ketter N, Brashear HR, Bogert J, Di J, Miaux Y, Gass A, Purcell DD, Barkhof F, Arrighi HM.

J Alzheimers Dis. 2017;57(2):557-573. doi: 10.3233/JAD-160216.

Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study

Koenig AM, Mechanic-Hamilton D, Xie SX, Combs MF, Cappola AR, Xie L, Detre JA, Wolk DA, Arnold SE.

Alzheimer Dis Assoc Disord. 2017 Apr-Jun;31(2):107-113. doi: 10.1097/WAD.0000000000000202.

Placebo Effects in the Treatment of Noncognitive Symptoms of Alzheimer's Disease: Analysis of the CATIE-AD Data

Ozawa C, Roberts R, Yoshida K, Suzuki T, Lebowitz B, Reeves S, Howard R, Abe T, Mimura M, Uchida H.

J Clin Psychiatry. 2017 Nov/Dec;78(9):e1204-e1210. doi: 10.4088/JCP.17m11461.

Donepezil 23 mg in Asian patients with moderate-to-severe Alzheimer's disease

Han SH, Lee JH, Kim SY, Park KW, Chen C, Tripathi M, Dash A, Kubota N.

Acta Neurol Scand. 2017 Feb;135(2):252-256. doi: 10.1111/ane.12571. Epub 2016 Feb 29.

Negative Aging Stereotypes Impair Performance on Brief Cognitive Tests Used to Screen for Predementia

Mazerolle M, Régner I, Barber SJ, Paccalin M, Miazola AC, Huguet P, Rigalleau F.

J Gerontol B Psychol Sci Soc Sci. 2017 Oct 1;72(6):932-936. doi: 10.1093/geronb/gbw083.

The Bingo Card Sign as an Early Symptom of Alzheimer's Disease

Hawco CLA, Weaver DF.

Ir Med J. 2017 Apr 10;110(4):551.

Near-infrared spectroscopy (NIRS) and vagus somatosensory evoked potentials (VSEP) in the early diagnosis of Alzheimer's disease: rationale, design, methods, and first baseline data of the Vogel study

Polak T, Herrmann MJ, Müller LD, Zeller JBM, Katzorke A, Fischer M, Spielmann F, Weinmann E, Hommers L, Lauer M, Fallgatter AJ, Deckert J.

J Neural Transm (Vienna). 2017 Nov;124(11):1473-1488. doi: 10.1007/s00702-017-1781-0. Epub 2017 Sep 1.

Galantamine Response Associates with Agitation and the Prefrontal Cortex in Patients with Alzheimer's Disease

Nakayama S, Suda A, Nakanishi A, Motoi Y, Hattori N.

J Alzheimers Dis. 2017;57(1):267-273. doi: 10.3233/JAD-160902.

Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)

Nave S, Doody RS, Boada M, Grimmer T, Savola JM, Delmar P, Pauly-Evers M, Nikolcheva T, Czech C, Borroni E, Ricci B, Dukart J, Mannino M, Carey T, Moran E, Gilaberte I, Muelhardt NM, Gerlach I, Santar

J Alzheimers Dis. 2017;58(4):1217-1228. doi: 10.3233/JAD-161309.

Comprehensive effects of galantamine and cilostazol combination therapy on patients with Alzheimer's disease with asymptomatic lacunar infarction

Hishikawa N, Fukui Y, Sato K, Ohta Y, Yamashita T, Abe K.

Geriatr Gerontol Int. 2017 Oct;17(10):1384-1391. doi: 10.1111/ggi.12870. Epub 2016 Aug 31.